A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers

NCT04405466 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 417

Last updated 2022-05-25

No results posted yet for this study

Summary

This is a prospective, epidemiological, cohort study to assess the feasibility of screening healthy asymptomatic workers for the presence of severe acute respiratory syndrome SARS-CoV-2 by pharyngeal swaps and serology at baseline, day 21 and day 40.

Conditions

Interventions

PROCEDURE

Blood sampling

Blood samples

PROCEDURE

Throat swab

Throat swab

Sponsors & Collaborators

  • Miltenyi Biomedicine GmbH

    lead INDUSTRY

Principal Investigators

  • Barbara von Ingersleben, Dr. · Miltenyi Biotec B.V. & Co. KG

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-22
Primary Completion
2020-11-05
Completion
2020-12-17

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04405466 on ClinicalTrials.gov